[Compliance of the hypertensive patient in medical practice--analysis of an observation study. 2].
In a subgroup of 301 hypertensive patients out of the user--observation study ("Anwendungsbeobachtung") with Renitec und CO-Renitec we studied which compliance-improving methods are effective. We tested the effects of blood pressure self-measurement and of an exclusive conversation with the patients. It could be shown, at least in our approach, that the conversation with the patient resulted in a lighter efficacy than blood pressure self-measurement: > 80% compliance was found in 80% of the patients, compared with only 40% of the patients with standard care.
Magometschnigg
D
D
Gesellschaft für klinische Pharmakologie, Wien.
Hitzenberger
G
G
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004656:Enalapril / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage* / Q000009:adverse effects; D006973:Hypertension / Q000188:drug therapy*; D010349:Patient Compliance
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004338:Drug Combinations; D006852:Hydrochlorothiazide; D004656:Enalapril
Die Compliance des Hypertonikers in der ärztlichen Praxis--Analyse einer Anwendungsbeobachtung. 2. Teil.